Compare CCOI & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCOI | TXG |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 2.1B |
| IPO Year | N/A | 2019 |
| Metric | CCOI | TXG |
|---|---|---|
| Price | $22.14 | $16.20 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 8 | 13 |
| Target Price | ★ $30.25 | $15.42 |
| AVG Volume (30 Days) | 1.4M | ★ 1.9M |
| Earning Date | 11-06-2025 | 02-11-2026 |
| Dividend Yield | ★ 18.00% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $907,233,000.00 | $641,814,000.00 |
| Revenue This Year | $4.50 | $4.50 |
| Revenue Next Year | $2.63 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.92 |
| 52 Week Low | $15.96 | $6.78 |
| 52 Week High | $84.06 | $20.34 |
| Indicator | CCOI | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 46.30 | 47.14 |
| Support Level | $21.76 | $15.82 |
| Resistance Level | $22.72 | $16.86 |
| Average True Range (ATR) | 1.35 | 0.75 |
| MACD | 0.45 | -0.14 |
| Stochastic Oscillator | 31.65 | 29.68 |
Cogent carries over one-fifth of the world's internet traffic on its network, providing high-capacity services to businesses. Cogent's corporate customers are in high-rise office buildings, where the firm provides two types of connections: dedicated internet access, which connects them to the internet, and virtual private networking, which offers an internal network for employees in different locations. Cogent's corporate customers are exclusively in North America and account for nearly half of the firm's revenue. Cogent's netcentric customers include internet service providers and content providers, to which Cogent provides internet transit. They hand traffic to Cogent in data centers and rely on Cogent to deliver it. About half of netcentric revenue is from outside the US.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).